Literature DB >> 11432803

Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.

T K Said1, R C Moraes, U Singh, F S Kittrell, D Medina.   

Abstract

The level of circulating ovarian hormones (estrogen and progesterone) alone or in combination with pituitary hormones have a potent mitogenic impact in the normal mammary gland, and they also play a pivotal role in the development and progression of mammary carcinoma. The differential effects of hormones on the molecular components of cyclin-dependent kinase (cdk) complexes in mammary epithelium of the hormone-dependent ductal outgrowth line, EL11, and the hormone-independent alveolar outgrowth line, TM2L, were the focus of this study. The two outgrowth lines, which represent early stages in mammary hyperplasia, were compared with normal mammary gland at different hormonal conditions: control, hormone stimulated by pituitary isograft, and hormone depleted by ovariectomy. Hormonal stimulation by a pituitary isograft resulted in DNA synthesis and lobuloalveolar development of normal mammary ducts, DNA synthesis but no lobuloalveolar development in the EL11 ductal outgrowth, and no changes either in DNA synthesis or in lobuloalveolar morphology in the TM2L outgrowth. The levels of cdk4- and cyclin D1-associated kinase activities were correlated with cell proliferation in only the alveolar phenotypes (i.e., in only hormonally stimulated normal virgin gland and in alveolar mammary outgrowth), whereas cyclin D2-dependent kinase activity was correlated with cell proliferation in only the alveolar preneoplasia. p16(INK4a) and p21(Cip1) protein levels were decreased at the earliest stages of preneoplasia, i.e., at immortalization, and were independent from changes in cyclin D1, which occurred later in preneoplasia. Although all cdk inhibitors changed in concordance with hormonal status reflected by proliferation levels, p27(Kip1) was the only cdk inhibitor that was up-regulated at the earliest stages of preneoplasia and may have a unique role in blocking alveolar differentiation in response to the loss of one or more of the cell cycle-negative regulators. We hypothesize that up-regulation of p27(Kip1) prevents immortalized ductal outgrowths (EL11) from progressing to the neoplastic state, even under hormonal stimulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432803

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  15 in total

Review 1.  Cell cycle genes in a mouse mammary hyperplasia model.

Authors:  Thenaa K Said; Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

Review 2.  Growth factor regulation of cell cycle progression in mammary epithelial cells.

Authors:  Malinda A Stull; Anne M Rowzee; Aimee V Loladze; Teresa L Wood
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

3.  TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.

Authors:  Florence Gizard; Romain Robillard; Barbara Gross; Olivier Barbier; Françoise Révillion; Jean-Philippe Peyrat; Gérard Torpier; Dean W Hum; Bart Staels
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

4.  The CDK4/6 inhibitor PD0332991 reverses epithelial dysplasia associated with abnormal activation of the cyclin-CDK-Rb pathway.

Authors:  M Carla Cabrera; Edgar S Díaz-Cruz; Bhaskar V S Kallakury; Michael J Pishvaian; Clinton J Grubbs; Donald D Muccio; Priscilla A Furth
Journal:  Cancer Prev Res (Phila)       Date:  2012-04-16

5.  A study to investigate the role of p27 and cyclin E immunoexpression as a prognostic factor in early breast carcinoma.

Authors:  Komala Pillay; Heather McCleod; Runjan Chetty; Pauline Hall
Journal:  World J Surg Oncol       Date:  2011-03-16       Impact factor: 2.754

6.  TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1.

Authors:  Florence Gizard; Romain Robillard; Olivier Barbier; Brigitte Quatannens; Anne Faucompré; Françoise Révillion; Jean-Philippe Peyrat; Bart Staels; Dean W Hum
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

7.  Transcriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression.

Authors:  Jeremy S Schaefer; Yamini Sabherwal; Heidi Y Shi; Venkataraman Sriraman; JoAnne Richards; Alex Minella; David P Turner; Dennis K Watson; Ming Zhang
Journal:  J Biol Chem       Date:  2010-02-05       Impact factor: 5.157

8.  Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2.

Authors:  Lisa K Pierson-Mullany; Carol A Lange
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

9.  Ptch1 is required locally for mammary gland morphogenesis and systemically for ductal elongation.

Authors:  Ricardo C Moraes; Hong Chang; Nikesha Harrington; John D Landua; Jonathan T Prigge; Timothy F Lane; Brandon J Wainwright; Paul A Hamel; Michael T Lewis
Journal:  Development       Date:  2009-03-18       Impact factor: 6.868

10.  Genes related to suppression of malignant phenotype induced by Maitake D-Fraction in breast cancer cells.

Authors:  Eliana Noelia Alonso; Manuela Orozco; Alvaro Eloy Nieto; Gabriela Andrea Balogh
Journal:  J Med Food       Date:  2013-07       Impact factor: 2.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.